Saya Biologics and Innovent Biologics announce strategic collaboration to expand access to oncology therapies in Mexico
Saya Biologics will register and commercialize Bevacizumab in Mexico, while Innovent Biologics will develop and supply the oncology biosimilar product. MEXICO CITY, MEXICO CITY, MEXICO, November 26, 2025 /EINPresswire.com/ -- Saya Biologics ( …